BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Fusaric Acid

A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis.

300+ PubMed studies analyzed · 2 RCTs · Evidence Score: 36.8

Research Domains

Fusaric Acid has been studied across 18 research domains including 🧠 Focus & Attention, 🌤️ Mood & Depression, 🔬 Oncology, 🫁 Liver & Detox, 🔬 Inflammation. The primary research focus is 🧠 Focus & Attention with 15% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Fusaric Acid, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Picloram
5 shared targets
Mimosine
3 shared targets
Guanazole
4 shared targets
Dihydroxyphenylalanine
4 shared targets
Harmaline
6 shared targets
Cefotetan
4 shared targets
Ethoxyquin
6 shared targets
Cefdinir
3 shared targets
ag490
5 shared targets
cycloserine
3 shared targets
Loading evidence profile...

This evidence profile for Fusaric Acid is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.